Machine learning-based preeclampsia risk prediction

Patients who underwent autologous stem cell transplantation (ASCT) for diffuse cutaneous systemic sclerosis (dcSSc), also known as scleroderma, did no better than others receiving conventional

Al­ly Bridge Group, whose re­cent suc­cess­es in­clude CG On­col­o­gy‘s eye-pop­ping IPO, said it pro­mot­ed two peo­ple to head up its pri­vate eq­ui­ty strate­gies across biotech